baber/WOPTO huggingface dataset:
Patent NZ-270869-A (NZ)
Title: Dispersion insensitive optical transmission: data stream encoded as a ternary signal modulated onto carrier
Inventor: PRICE ALISTAIR
IPC: H04B10/2513
Filed: 1995-04-04
Abstract: PCT No. PCT/FR95/00510 Sec. 371 Date Dec. 13, 1995 Sec. 102(e) Date Dec. 13, 1995 PCT Filed Apr. 20, 1995 PCT Pub. No. WO95/29539 PCT Pub. Date Nov. 2, 1995An optical transmission method and device consisting of coding a binary data pattern (SI) to be transmitted in the form of a second binary signal (SM), by differential coding; filtering the second binary signal (SM) to obtain a duobinary signal (SMF having three meaningful values (-1, 0+/- epsilon , +a) and a narrower bandwidth; and modulating an optical carrier according to the values assumed by the filtered signal (SMF), the modulated carrier having a maximal amplitude to represent the maximal value (+a) and the minimal value (+a) of the duobinary signal (SMF), the phase of the modulated carrier being shifted by  theta 1 and  theta 2= theta 1+180 DEG , respectively, and a minimal amplitude to represent values (0+/- epsilon ) near 0 if the duobinary signal. The method of this invention is suitable for long distance fiber-optic transmissions.
Patent NZ-283366-A (NZ)
Title: Monoclonal antibodies recognizing tie receptors (receptor tyrosine kinase) and their use
Inventor: ALITALO KARI
IPC: C07K14/71
Filed: 1995-03-29
Abstract: The present invention relates to an anti-Tie monoclonal antibody, 3C4C7G6, which is useful as a diagnostic tool for detecting angiogenesis-associated with neoplasia, wound healing, and a variety of other angiogenesis associated diseases and for radiological imaging of blood vessels. In addition, the disclosed antibody is useful as a therapeutic agent.
Patent NZ-288185-A (NZ)
Title: Particulate pharmaceutical formulation containing coated cores comprising at least 80% of an inert carrier having a friability of <20%; the inert carrier can be calcium carbonate
Inventor: NORLING TOMAS
IPC: A61K9/00
Filed: 1995-06-14
Abstract: A novel drug delivery system, e.g. in the form of a solid dosage form or a liquid formulation based on a pharmaceutical multiple unit in the form of cores such as, e.g., coated cores. The pharmaceutical formulations are based on a novel principle allowing preparation of cores such as, e.g., cores in the form of pellets, i.e. substantially spheric particles which have such a mechanical strength (expressed in terms of friability) that the cores are sufficiently robust to substantially remain intact after having been subjected to coating by standard pharmaceutical procedures well known by a person skilled in the art such as, e.g., a coating process involving a fluidized bed process. A spray-drying process for the preparation of the pharmaceutical formulation is also described.
Patent NZ-305133-A (NZ)
Title: Tricyclic compounds, preparation and pharmaceutical compositions thereof
Inventor: ALFONSO ADRIANO
IPC: A61K31/4433
Filed: 1996-03-20
Abstract: A method of inhibiting Ras function and therefore inhibiting cellular growth is disclosed.  The method comprises the administration of a compound of formula (Ia), (Ib) or (Ic) wherein: R and R1 are H, alkyl, halogeno, OH, alkoxy, NH2, alkylamino, dialkylamino, CF3, SO3H, CO2R3, NO2, SO2NH2, or CONHR4; n is 0 or 1; R2 is a group of the formula R5C(O)-, R5CH2C(O)-, R5C(R6)2C(O)-, R5SO2-, R5CH2SO2-, R5SCH2C(O)-, R5OC(O)-, R5NHC(O)-, R5C(O)C(O)- or R5SC(O)-; R5 is alkyl, aryl, arylalkyl, arylalkenyl, heteroaryl, heteroarylalkyl, heteroarylalkenyl or heterocycloalkyl; and R6 is alkyl or C(R6)2 is a carboxyclic ring; or pharmaceutically acceptable salts thereof.
Patent NZ-331363-A (NZ)
Title: Liquid oral compositions comprising a calcium compound and an acidulant
Inventor: PARKER DAVID MYATT
IPC: A23L1/304
Filed: 1997-02-12
Abstract: The acidic oral compositions are said to have reduced tooth erosion characteristics, especially acid beverages such as fruit juice drink concentrates, or oral healthcare products such as mouthwashes.  They are prepared by adding a calcium compound to the acid composition so that the mol ratio of calcium to acid ranges from 0.3 to 0.8, and the pH of the composition, if necessary after adjustment with an alkali, is from 3.5 to 4.5.
Patent NZ-500633-A (NZ)
Title: Vector
Inventor: KINGSMAN SUSAN MARY
IPC: C07K14/47
Filed: 1998-06-04
Abstract: A vector comprising at least one nucleotide sequence (NS) encoding a tumour binding protein capable of recognising a tumour cell; wherein the tumour binding protein recognises a trophoblast cell surface antigen, wherein the vector is capable of expressing the tumour binding protein in a mammalian cell and is capable of delivering a nucleotide sequence of interest (NOI) encoding a product of interest (POI) to a tumour.
Patent NZ-501255-A (NZ)
Title: Cross-linkable surface coatings having a latex seed core and a monomer, the monomer having acid functional pendant moieties and being capable of forming a stable enamine structure by reaction with amines
Inventor: TRUMBO DAVID L
IPC: C09D133/06
Filed: 1998-05-28
Abstract: A single-package aqueous polymeric initial formulation comprising: i) A polymeric ingredient having a latex seed core with a number average particle size from 20 nanometers to 60 nanometers and a polymerisable monomeric ingredient, the polymerisable monomeric ingredient having both acid functional pendant moieties and pendant moieties having the ability to form stable enamine structures by reaction with amines, the pendant moieties containing a divalent group of the structure shown: where R1 is H, alkyl or phenyl; ii) A polyfunctional amine having at least two amine functional moieties. iii) An effective amount of base to inhibit crosslinking of the polymeric ingredient with the polyfunctional amine. iv) An evaporable aqueous carrier. The seed core is of a different chemical composition than the polymerisable monomeric ingredient.
Patent NZ-505860-A (NZ)
Title: Two-piece nailer magazine and method therefor
Inventor: CURTIS PATRICK J
IPC: B25C1/00
Filed: 2000-07-19
Abstract: A fastener driving tool magazine for receiving a collated strip of fasteners, comprises a first magazine portion 110 having an elongated first side wall with a first front end portion and a first rear end portion.  The first magazine portion has a first lower portion with a tongue  136 protruding therefrom.  A second magazine portion 120 has an elongated second side wall with a second front end portion and a second rear end portion.  Second magazine portion 120 has a second lower portion with a groove 150.  Tongue 136 of first magazine portion 110 is disposable and frictionally retainable in groove 150 of second magazine portion 120 when the first and second magazine portions are assembled.
Patent NZ-506157-A (NZ)
Title: Process for making a stable organosilanized colloidal silica suspension
Inventor: VAN VLASSELAER PETER
IPC: C01B33/149
Filed: 1999-01-07
Abstract: A method of bulk preparation of a stable organosilanized colloidal silica suspension in an aqueous environment, comprises providing an aqueous organosilane solution having a pH in the range of about 2-3 and heated to about 80oC for about 1 hour.  A colloidal silica suspension is added to the organosilane solution to form an organosilane-colloidal silica mixture having a final concentration of between about 5% (v/v) and about 10% (v/v) organosilane. The pH of the organosilane-colloidal silica mixture is then adjusted to a pH greater than about 6.0. The suspension is then cured for a period of time effective to produce a stable colloidal suspension, as evidenced by lack of precipitate formation in the presence of physiological salt or acid, wherein said resulting stable colloidal silica suspension is aqueous and non-toxic to cells.
Patent NZ-509762-A (NZ)
Title: 5-Azatricyclo[3.3.1.1<3,7>]decane derivatives, pharmaceuticals thereof, and their use as cholinergic receptor agonists and antagonists
Inventor: CAI XIONG
IPC: C07D/
Filed: 1999-08-16
Abstract: The present brings a solution in the form of products that are useful as cholinergic receptor agonists and antagonists.  In a preferred embodiment, the compounds can act selectively on certain muscarinic receptors, particularly on M4 receptors, with reduced cholinergic side effects.  Consequently, they are well suited for therapeutic use in the treatment of pain and other neurologic and psychiatric disorders.  The compounds of the present invention are azaadamantanes, azanoradamantanes and azahomoadamantanes. In addition, the disclosed provides pharmaceutical compositions comprising the compounds and methods of treating pain and neurologic and psychiatric disorders with the pharmaceutical compositions.
Patent NZ-511316-A (NZ)
Title: Electronic poker game with restricted value wildcards
Inventor: BENNETT NICHOLAS LUKE
IPC: A63F1/00
Filed: 2001-04-24
Abstract: A gaming machine includes a display and a game controller arranged to play a game of poker. The hand of cards is randomly selected from at least one deck of cards and is displayed on the machine display. If a winning hand results, the machine pays a prize. There is at least one multifunction card (110) which substitutes for at least two, but less than all, standard cards of the deck. Multi-function cards can carry, in addition to their face value and suit representation (114), at least one additional function-performing symbol e.g. another suit (112). A wager made by a player governs the number of suits appearing on a multi-function card.
Patent NZ-513249-A (NZ)
Title: Automated learning system (e.g neural network)
Inventor: CLEARY JOHN GERALD
IPC: G06N3/02
Filed: 2001-07-31
Abstract: A method of operating a software based machine learning system employing a feature data structure comprises: (i) obtaining a sample record for which the probability of the record belonging to aero or more categories is to be indicated, (ii) identifying each of the features present within the record, (iii) supplying at least a portion of the elements of the feature data structure to a Naïve Bayesian prediction algorithm where the elements supplied are associated with features identified within the sample record, and (iv) calculating an indication of the probability of the sample record belonging to zero or more categories using the Naïve Bayesian prediction algorithm through summing the category ratings of the supplied elements of the feature data structure. Also described in a method of testing software-based machine learning system employing a feature data structure comprises: (i) selecting a test record from input data used to create a feature data structure of the system, (ii) subtracting the test records category rating or ratings from a total data structure of the system, (iii) identifying the features present in the test record, (iv) subtracting the test record's category rating or ratings from the elements of the feature data structure associated with each element identified within the test record, (v) using the updated feature data structure, updated total data structure and test record as inputs to a Naïve Bayesian prediction algorithm to calculate a probability indication for a category or categories which the test record may belong to, and (vi) comparing a calculated probability indication with the category rating or ratings of the test record.
Patent NZ-525009-A (NZ)
Title: Pyrazole compounds useful as protein kinase inhibitors
Inventor: DAVIES ROBERT
IPC: A61P3/10
Filed: 2001-09-14
Abstract: Disclosed are compounds of formula III, wherein: Ring D is a 5-7 membered monocyclic ring or 8-10 membered bicyclic ring selected from aryl, heteroaryl, heterocyclyl or carbocyclyl, being optionally substituted, Rx and Ry are taken together with their intervening atoms to form a fused, unsaturated or partially unsaturated, 5-8 membered carbocyclo ring, wherein any substitutable carbon on the fused ring formed by Rx and Ry is substituted by oxo or T-R3, R2 and R2' are independently selected from -R, -T-W-R6, or R2 and R2' are taken together to form a fused 5-8 membered, unsaturated or partially unsaturated ring having 0-3 ring heteroatoms selected from nitrogen, oxygen, or sulfur, and the remaining substituents are defined herein. The compounds are used in the manufacture of medicaments for the inhibition of GSK-3, Aurora, or Src activity.
Patent NZ-526648-A (NZ)
Inventor: CARRINGTON CEDRIC GERALD
IPC: F26B21/08
Filed: 2003-06-24
Abstract: A process and apparatus for drying pastes, liquors and aggregate materials by means of a heat integrated and/or heat pumping process and/or apparatus is disclosed. This includes a heat pump or heat integrated apparatus operable in a drying apparatus with the heat pump evaporator (36) or cold heat exchanger in primary thermal contact with the drying gas medium (33) after said drying gas medium (33) has taken up moisture from the material being dried (35) and the heat pump condenser (14) or hot heat exchanger (36) in primary thermal contact with the material being dried and with both the drying gas medium (33) and any heat pump refrigerant in nominally closed loop circulation paths (22). This process and apparatus may provide improved efficiency and reduced costs by reducing the required flow of drying gas through the system since that drying gas is no longer the primary means for supplying heat to the material being dried.
Patent NZ-533105-A (NZ)
Title: Systems, methods, and software for classifying documents
Inventor: AL-KOFAHI KHALID
IPC: G06F17/30
Filed: 2002-11-01
Abstract: Systems, methods, and software to aid classification of text, such as headnotes and other documents, to target classes in a target classification system. For example, one system computes composite scores based on: similarity of input text to text assigned to each of the target classes; similarity of non-target classes assigned to the input text and target classes; probability of a target class given a set of one or more non-target classes assigned to the input text; and/or probability of the input text given text assigned to the target classes. The exemplary system then evaluates the composite scores using class-specific decision criteria, such as thresholds, ultimately assigning or recommending assignment of the input text to one or more of the target classes. The exemplary system is particularly suitable for classification systems having thousands of classes.
Patent NZ-534568-A (NZ)
Title: Use of insect esterases, such as alpha-carboxylesterases, in the bioremediation of pyrethroid residues contaminating the environment and horticultural commodities
Inventor: RUSSELL ROBYN JOYCE
IPC: C12Q1/44
Filed: 2002-02-06
Abstract: Described are methods and enzymes for degrading hydrophobic ester pesticides and toxins. In particular, the use of Dipteran esterase, and mutants thereof, in the bioremediation of hydrophobic ester pesticides and toxins residues, such as pyrethroid residues, contaminating the environment and horticultural commodities is described.
Patent NZ-534657-A (NZ)
Title: 5-phenythiazole derivatives and use as phosphatidylinositol 3-kinase (Pi3 kinase) inhibitors
Inventor: BRUCE IAN
IPC: A61P31/04
Filed: 2003-02-27
Abstract: 5-phenythiazole derivative compounds of formula (I) in free form or salt form are disclosed, wherein R1, R2, R3, R4, and R5, have the meanings as indicated in the specification. These compounds particularly exhibit the inhibition of phosphatidylinositol 3-kinase (Pi3 kinase) enzymes, especially the gamma isoform (p110gamma), which are responsible for generating phosphorylated signalling products, hence, these compounds are useful for treating diseases mediated by phosphatidylinositol 3-kinase (Pi3 kinase). Pharmaceutical compositions that contain these compounds and processes for preparing these compounds are also disclosed.
Patent NZ-535672-A (NZ)
Title: Depth and width adjustable display track unit with removable partitions
Inventor: JAY RICHARD
Filed: 2003-03-28
Abstract: This invention is an integrally moulded display floor for a gravity feed display tray where the floor has no integrally moulded side walls extending upward but has a plurality of longitudinal ribs which can receive upward extending partitions which are releasably attachable to the floor and extend longitudinally, thus dividing the display tray into laterally spaced compartments. Each display tray has opposite marginal side walls extending downward and transversely extending support beams intersecting the longitudinal ribs. The downward extending side walls extend below the bottom surfaces of the longitudinal ribs thus establishing a basement where the bottom surfaces of the ribs constitute the ceiling of the basement. This basement is a space suitable for receiving downward extending tabs of the partition to engage and stabilize such partition with the display track. The basement also provides suitable space for lateral extending coupling means from one display track to the next for coupling adjacent display tracks to provide a wider transverse area thereof. Furthermore, the basement allows space for further coupling members extending from the rear end of any display track element to the front end of the next for coupling thereto. These coupling elements are flexible hook type members which engage into mating recesses and are releasable upon deflecting and/or bending one with respect to the other. A variety of additional coupling means are provided for insuring that the partition is securely engaged but readily releasable from the display track and repositionable on the surface of the display track between any two pair of adjacent longitudinal ribs.
Patent NZ-546584-A (NZ)
Title: Method for producing gamma-carboxylated proteins
Inventor: FENGE CHRISTEL
IPC: C12N9/64
Filed: 2004-10-12
Abstract: Disclosed is a eukaryotic host cell comprising at least one expression vector comprising: a nucleic acid molecule encoding a protein requiring gamma-carboxylation and associated expression control sequences comprising a first promoter and a nucleic acid molecule encoding a gamma-glutamyl carboxylase and associated expression control sequences comprising a second promoter, wherein the first promoter is selected from human cytomegalovirus (hCMV) immediate early promoter, pEF-lalpha, pRSV or pUbC, and the second promoter is selected from SV40 immediate early promoter, minimized FIX promoter or HSV Thymidine kinase promoter; with the proviso that the host cell is not within a human. The eukaryotic host cells disclosed are useful in the manufacture of therapeutic proteins, in particular coagulation related proteins.
Patent NZ-552877-A (NZ)
Title: Carboranylporphyrins and uses thereof
Inventor: WU HAITAO
IPC: C07D487/22
Filed: 2005-06-22
Abstract: Disclosed is a compound of formula (1), wherein the substituents are as described in the specification. Also disclosed is the use of the compound for imaging a tumor and surrounding tissue.
Patent NZ-554075-A (NZ)
Title: Method of deflavoring soy-derived materials using electrodialysis
Inventor: BROWN PETER H
IPC: A23L11/30
Filed: 2005-09-14
Abstract: Disclosed is a method for preparing deflavoured soy protein material from soy-derived materials such as soy milk, soy concentrates, and soy protein isolates. The soy-derived material is deflavoured by adjusting the pH (to about 9 to about 12) of an aqueous composition of such material, using membrane electrodialysis. This pH shift solubilises the soy proteins and releases the flavouring compounds. Thereafter, the pH-adjusted composition is passed through an ultrafiltration membrane having a molecular weight cutoff up to about 50,000 Daltons. This step is preformed under conditions at which the flavouring compounds pass through the membrane, leaving the retained soy material with improved flavour.
Patent NZ-563076-A (NZ)
Title: Wall box mounting including integral tabs in the sides, flush mounting.
Inventor: GRANSBURY KENNETH BASIL
Filed: 2007-11-01
Abstract: A wall box is disclosed. The wall box 10 comprises a plurality of sides 11, 12, 13, 14. At least one of the plurality of sides includes an integral tab portion 20. The tab portion is able to be bent outwards to provide a mounting surface for mounting to a support.
Patent NZ-568107-A (NZ)
Title: 2-(phenyl or heterocyclic)-1H-phenanthro[9,10-D]imidazoles as mPGES-1 inhibitors
Inventor: CHAU ANH
IPC: A61K31/4184
Filed: 2006-11-21
Abstract: Disclosed are imidazole compounds represented by formula (B), or pharmaceutically acceptable salts thereof. Also disclosed is the use of the compounds of formula (B) in the preparation of a medicament for treating a microsomal E synthase-1 mediated disease or condition such as acute or chronic pain, osteoarthritis, rheumatoid arthritis, bursitis, ankylosing sponylitis and primary dysmenorrhea.
Patent NZ-571988-A (NZ)
Title: Process for the production of benzopyran-2-ol derivatives useful in preparation of tolterodine, fesoterodine and other pharmaceutically useful compounds
Inventor: AHMAN JENS BERTIL
IPC: C07D311/20
Filed: 2007-05-21
Abstract: Disclosed is a process for the production of a compound of formula (I), wherein Y is selected from CH3, CH2OH, CH2CH2OH, CH2Br and Br, involving reacting a compound of formula (II) with trans-cinnamaldehyde (III) in the presence of a secondary amine compound in which the product is then treated with acid to afford the compound of formula (I) wherein the substituents relating to preceding compounds are defined in the specification. Also disclosed is a process for the production of formula (IV) or a salt thereof involving the steps of, producing compound of formula (I) via said process noted above, followed by reductively aminating the compound of formula (I) with dissopropylamine and where desired converting the resulting compound into a salt. Furthermore, a process for the production of fesoterodine using the prepared compounds as recited herein is also disclosed.
Patent NZ-572808-A (NZ)
Title: Compositions for raising an immune response comprising an antigen and a targeting moiety for lymph-resident dendritic cells
Inventor: BELZ GABRIELLE THERESE
IPC: A61K39/245
Filed: 2007-05-18
Abstract: Disclosed is an immunogenic composition for raising an immune response to an antigen, the composition comprising the antigen and a targeting moiety specific for lymph node resident dendritic cells. Further disclosed is the use of a targeting moiety specific for lymph node resident dendritic cells in the production of an immunogenic composition with an antigen to increase the efficiency of a booster vaccination comprising the immunogenic composition the immunogenic in raising a secondary immune response in a booster vaccination when compared to using the antigen alone.
Patent NZ-579603-A (NZ)
Title: Separation of a liquid food product using at least two separators connected in parallel
Inventor: MANSSON ROLF
IPC: B04B5/10
Filed: 2008-04-01
Abstract: A method of improving the efficiency of fat separation in the separation of a liquid food product with a certain fat content. The method comprises the method step that the liquid food product is caused to pass first and second separators (1, 2) connected in parallel, in which the product is divided up into a lighter and a heavier phase. The first separator is regulated so that the lighter phase will have a fat content which is less than 15 %. The lighter phase from the first separator is led into the inlet conduit (4) to the second separator.